Cantor Fitzgerald initiated coverage of 4D Molecular with an Overweight rating and $32 price target.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on FDMT:
- 4D Molecular receives EMA PRIME designation for 4D-150
- 4DMT Appoints Uneek Mehra as Chief Financial and Business Officer
- 4D Molecular chief financial, business officer August Moretti to step down
- 4DMT to Participate in Upcoming Investor Conferences
- 4D Molecular begins enrollment in Phase 2 DME trial, expands Phase 2 AMD trial